Anxiety, Depression, and Chronic Illness: An Epigenetic and Nutrigenomic Approach
Over the last thirty years, how many of you have noticed the rise in anxiety and depression? Have you also noticed an increase in ‘autoimmune’ disease(s)? Have you seen new treatments develop that are resolving these peoples’ suffering? Your answer to that last question is probably “no.”
According to a study commissioned by the ADAA (Anxiety and Depression Association of America), a staggering 40 million American adults (and over 25% of American adolescents) are affected by anxiety disorders. Of those 40 million, 7 million suffer with general anxiety disorder, 15 million with social anxiety disorder, and 14.8 million with major depressive disorder. (1) The same study reveals that $42 billion per year are spent on anxiety disorder treatments, which averages to around $1,050 per person in a year. These statistics are actually from a 1999 study, so this data is almost 20 years old. I believe our rates of anxiety, depression, and autoimmune disease have increased in an exponential manner since these statistics were published. Read more →
Recent Comments